4 . 2020

Results of truncal mechano-chemical obliteration in patients with varicose disease and venous ulcers

Abstract

Background. Treatment of venous trophic ulcers is a serious medical and social problem. Surgical method of elimination of superficial venous reflux is the main pathogenesis procedure in varicose vein disease and venous ulcers, so the relevance of modern endovenous technologies in this group of patients is beyond doubt.

Aim. We aimed to evaluate the use of mechanico-chemical endovenous ablation (MOCA) with Flebogrif™ device for ablating the great saphenous vein in patients with varicose vein disease and open stasis venous ulcers in a two vascular centers.

Material and methods. A total of 6 patients (2 men and 4 women) underwent MOCA for varicose vein disease and venous trophic ulcers with vein occlusion catheter Flebogrif™. All patients were treated for below-knee great saphenous vein incompetence alone. The average diameter of great saphenous vein treated was 11.2±1.6 mm. 6 patients have average ulcer size of 6.3±3.5 cm². Ulcer duration before intervention ranged from 3 to 14 months. Patients were reviewed at an interval of 7 days, 1, 3, 6 and 12 months post procedure and underwent Duplex ultrasound.

Results. The great saphenous vein was completely occluded in six operated patients (100% anatomical success). There was no nerve injury or other complications after MOCA. These patients had an average of 1.5 month healing time. The mean length of follow-up was 8.2 months after procedure. There were no recurrent ulcers at 6.7 months after healing of them.

Conclusion. Mechanico-chemical endovenous ablation can be safe and effective in the treatment of patients with below-knee great saphenous vein insufficiency with venous ulcers. Randomized studies are necessary to further support our findings.

Keywords:varicose veins, endovenous mechano-chemical ablation, venous ulcer, FlebogrifTM

Funding. The study had no sponsor support.
Conflict of interests. The authors declare no conflict of interests.
Contribution. Development of the concept and design of the study, collection of clinical material, editing - Khryshchanovich V.Ya.; development of research design, analysis of the data obtained, statistical data processing - Proczka R.; analysis of the data obtained, preparation of the text - Mazur S.
For citation: Khryshchanovich V.Ya., Proczka R., Mazur S. Results of truncal mechano-chemical obliteration in patients with varicose disease and venous ulcers. Clinical and Experimental Surgery. Petrovsky Journal. 2020; 8 (4): 87-96. DOI: https://doi.org/10.33029/2308-1198-2020-8-4-87-96 (in Russian)

References

1. Carradice D. Superficial venous insufficiency from the infernal to the endothermal. Ann R Coll Surg Engl. 2014; 96 (1): 5-10. DOI: https://doi.org/10.1308/003588414X13824511650498

2. Coon W.W., Willis P.W., Keller J.B. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study. Circulation. 1973; 48 (4): 83946. DOI: https://doi.org/10.1161/01.cir.48.4.839

3. Chiesa R., Marone E.M., Limoni C., Volonte M., Schaefer E., Petrini O. Demographic factors and their relationship with the presence of CVI signs in Italy: the 24-cities cohort study. Eur J Vasc Endovasc Surg. 2005; 30 (6): 674 - 80. DOI: https://doi.org/10.1016/j.ejvs.2005.06.016

4. Cornwall J.V., Dore C.J., Lewis J.D. Leg ulcers: epidemiology and aetiology. Br J Surg. 1986; 73 (9): 693-6. DOI: https://doi.org/10.1002/bjs.1800730905

5. Cesarone M.R., Belcaro G., Nicolaides A.N., Geroulakos G., Griffin M., Incandela L., et al. «Real» epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology. 2002; 53 (2): 119-30. DOI: https://doi.org/10.1177/000331970205300201

6. Rabe E., Pannier F. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology. 2010; 25 (1): 64-7. DOI: https://doi.org/10.1258/phleb.2010.010s09

7. Lal B.K. Venous ulcers of the lower extremity: definition, epidemiology, and economic and social burdens. Semin Vasc Surg. 2015; 28 (1): 3-5. DOI: https://doi.org/10.1053/j.semvascsurg.2015.05.002

8. Kanchanabat B., Stapanavatr W., Kanchanasut-tiruk P. Total superficial vein reflux eradication in the treatment of venous ulcer. World J Surg. 2015; 39 (5): 13015. DOI: https://doi.org/10.1007/s00268-014-2935-y

9. Yamaki T., Nozaki M., Fujiwara O., Yoshida E. Comparative evaluation of duplex-derived parameters in patients with chronic venous insufficiency: correlation with clinical manifestations. J Am Coll Surg. 2002; 195 (6): 822-30. DOI: https://doi.org/10.1016/s1072-7515(02)01670-8

10. O’Donnell T.F., Passman M.A., Marston W.A., Ennis W.J., Dalsing M., Kistner R.L., et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2014; 60: 3S-59S. DOI: https://doi.org/10.1016/j.jvs.2014.04.049

11. Barwell J.R., Davies C.E., Deacon J., Harvey K., Minor J., Sassano A., et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet. 2004; 363: 1854-9. DOI: https://doi.org/10.1016/S0140-6736(04)16353-8

12. Gohel M.S., Heatley F., Liu X., Bradbury A., Bul-bulia R., Cullum N., Epstein D.M., et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med. 2018; 378 (22): 2105-14. DOI: https://doi.org/10.1056/NEJMoa1801214

13. Sullivan L.P., Quach G., Chapman T. Retrograde mechanico-chemical endovenous ablation of infrageniculate great saphenous vein for persistent venous stasis ulcers. Phlebology. 2014; 29 (10): 654-7. DOI: https://doi.org/10.1177/0268355513501301

14. Van den Bos R.R., Neumann M., De Roos K.P., Nijsten T. Endovenous laser ablation-induced complications: review of literature and new cases. Dermatol Surg. 2009; 35 (8): 1206-14. DOI: https://doi.org/10.1111/j.1524-4725.2009.01215.x

15. Elias S., Raines J.K. Mechanochemical tumes-centless endovenous ablation: final results of the initial clinical trial. Phlebology. 2012; 27 (2): 67-72. DOI: https://doi.org/10.1258/phleb.2011.010100

16. Witte M.E., Zeebregts C.J., de Borst G.J., Reijnen M.M.P.J., Boersma D. Mechanochemical en-dovenous ablation of saphenous veins using the ClariVein: a systematic review. Phlebology. 2017; 32 (10): 649-57. DOI: https://doi.org/10.1177/0268355517702068

17. Zubilewicz T,. Terlecki P., Terlecki K., Przywara S., Rybak J., Ilzecki M. Application of endovenous mecha-nochemical ablation (MOCA) with Flebogrif™ to treat varicose veins of the lower extremities: a single center experience over 3 months of observation. Acta Angiol. 2016; 22 (4): 137-42. DOI: https://doi.org/10.5603/AA.2016.0012

18. Ciostek P., Kowalski M., Wozniak W., Mitek T., Myrcha P., Migda B. Phlebogriffe - a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study. Phlebol Rev. 2015; 23 (3): 72-7. DOI: https://doi.org/10.5114/pr.2015.57466

19. Tessari L., Cavezzi A., Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001; 27 (1): 58-60.

20. Lurie F., Passman M., Meisner M., Dalsing M., Masuda E., Welch H., et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020; 8 (3): 342-52. DOI: https://doi.org/10.10167j.jvsv.2019.12.075

21. Meissner H.M., Eklof B., Smith C.P., Dalsing M.C., DePalma R.G., Gloviczki P., et al. Secondary chronic venous disorders. J Vasc Surg. 2007; 46 (S): 68S-83S. DOI: https://doi.org/10.1016/jjvs.2007.08.048

22. Posnett J., Gottrup F., Lundgren H., Saal G. The resource impact of wounds on health-care providers in Europe. J Wound Care. 2009; 18: 154-61. DOI: https://doi.org/10.12968/jowc.2009.18.4.41607

23. Todd M. Compression in older people. Br J Nurs. 2019; 28 (9): 566. DOI: https://doi.org/10.12968/bjon.2019.28.9.566

24. Lane T., Bootun R., Dharmarajah B., Lim C.S., Najem M., Renton S., et al. A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins - final results of the Venefit versus Clarivein for varicose veins trial. Phlebology. 2017; 32 (2): 89-98. DOI: https://doi.org/10.1177/0268355516651026

25. Sun J.J., Chowdhury M.M., Sadat U., Hayes P.D., Tang T.Y. Mechanochemical ablation for treatment of truncal venous insufficiency: a review of the current literature. J Vasc Interv Radiol. 2017; 28 (10): 1422-31. DOI: https://doi.org/10.1016/jjvir.2017.07.002

26. Russian clinical guidelines for the diagnostics and treatment of chronic venous diseases. Flebologiya [Flebology]. 2018; 12 (3): 146-240. DOI: https://doi.org/10.17116/flebo20187031146 (in Russian)

27. Nicolaides A., Kakkos S., Baekgaard N., Com-erota A., De Maeseneer M., Eklof B., et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part II. Int Angiol. 2020 Mar 26. DOI: https://doi.org/10.23736/S0392-9590.20.04388-6

28. Kim S.Y., Safir S.R., Png C.Y.M., Faries P.L., Ting W., Vouyouka A.G., et al. Mechanochemical ablation as an alternative to venous ulcer healing compared with thermal ablation. J Vasc Surg Venous Lymphat Disord. 2019; 7: 699-705. DOI: https://doi.org/10.1016/j.jvsv.2019.05.005